Syner-G BioPharma Group is a pioneering company that offers comprehensive expertise in Chemistry, Manufacturing, and Controls (CMC), under the umbrella of CMC 360™. The company also specializes in medical writing services, encompassing various regulatory documents across multiple therapeutic areas and development phases. Additionally, their regulatory affairs services cover global strategic planning, agency meeting support, and electronic submissions worldwide. With a versatile skill set, the company guides assets through development challenges and evolving regulatory pathways, ensuring full compliance and high quality. Syner-G's proficiency spans diverse products including small molecules, peptides, biologics, monoclonal antibodies, and cell and gene therapy products.
The company's slogan, "To enable our clients to achieve success and enhance human health while inspiring our colleagues to excel! #weinspire," reflects their commitment to excellence and innovation.
Currently, information about the founding date, industries, headquarters, last investment, and last investment investors is not available.
There is no investment information
No recent news or press coverage available for Syner-G BioPharma Group.